Your browser doesn't support javascript.
loading
EEG parameters as endpoints in epilepsy clinical trials - An expert panel opinion paper.
Buchhalter, Jeffrey; Neuray, Caroline; Cheng, Jocelyn Y; D'Cruz, O'Neill; Datta, Alexandre N; Dlugos, Dennis; French, Jacqueline; Haubenberger, Dietrich; Hulihan, Joseph; Klein, Pavel; Komorowski, Robert W; Kramer, Lynn; Lothe, Amélie; Nabbout, Rima; Perucca, Emilio; der Ark, Peter Van.
Afiliação
  • Buchhalter J; Buchhalter Consulting, PLLC, 13030 N. 17th Place, Phoenix, AZ, USA. Electronic address: buchhalterj@gmail.com.
  • Neuray C; Department of Neurology, Neurocritical Care, and Neurorehabilitation, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Paracelsus Medical University, Salzburg, Austria. Electronic address: Caroline@epilog.care.
  • Cheng JY; Neurology Business Group, Eisai Inc., 200 Metro Blvd. Nutley, NJ 07110, USA. Electronic address: Jocelyn_Cheng@eisai.com.
  • D'Cruz O; OD Consulting and Neurological Services, PLLC, 825 Deseret Lane, Chapel Hill, NC 27516, USA. Electronic address: oneilldcruz@gmail.com.
  • Datta AN; Pediatric Neurology and Developmental Medicine Department, University Children's Hospital UKBB, University of Basel, Switzerland. Electronic address: alexandre.datta@ukbb.ch.
  • Dlugos D; Departments of Neurology and Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA USA. Electronic address: dlugos@email.chop.edu.
  • French J; Department of Neurology NYU Langone Health, NYU Grossman School of Medicine, USA. Electronic address: jacqueline.french@nyulangone.org.
  • Haubenberger D; Neurocrine Biosciences Inc., San Diego, CA, USA. Electronic address: dhaubenberger@neurocrine.com.
  • Hulihan J; Marinus, 5 Radnor Corporate Center, 100 Matsonford Rd, Suite 500, Radnor, PA 19087, USA. Electronic address: jhulihan@marinuspharma.com.
  • Klein P; Mid-Atlantic Epilepsy and Sleep Center, 6410 Rockledge Drive, Suite 610, Bethesda, MD 20817, USA. Electronic address: keinp@epilepsydc.com.
  • Komorowski RW; Ionis Pharmaceuticals Inc, 2855 Gazelle Court, Carlsbad, CA 92010, USA. Electronic address: rkomorowski@ionisph.com.
  • Kramer L; EisaiInc, 100 Tice Blvd, Woodcliff Lake, NJ, USA. Electronic address: lynn_kramer@eisai.com.
  • Lothe A; Zogenix International (now part of UCB), The Pearce Building, West Street, SL6 1RL Maidenhead, United Kingdom. Electronic address: Amelie.Lothe@ucb.com.
  • Nabbout R; Reference Centre for Rare Epilepsies, Department of Pediatric Neurology, Necker Enfants Malades hospital, Université de Paris cité, Institut Imagine, Paris, France. Electronic address: rima.nabbout@aphp.fr.
  • Perucca E; Department of Medicine (Austin Health), The University of Melbourne, Melbourne, VIC, Australia, and Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia. Electronic address: perucca@unipv.it.
  • der Ark PV; Janssen Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium. Electronic address: pvander5@its.jnj.com.
Epilepsy Res ; 187: 107028, 2022 11.
Article em En | MEDLINE | ID: mdl-36270075

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsia / Anticonvulsivantes Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsia / Anticonvulsivantes Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article